Diversion Program Essentials:
Data Driven Solutions for Minimizing Drug Waste and Diversion Risk
Overview
This discussion of specialists from Fresenius Kabi and Protenus regarding drug diversion addresses a complex issue from multiple angles, focusing on the journey from supply chain to diversion, the pivotal role of drug waste, strategies for minimizing waste, and the broader implications of such efforts.
The dialogue underscores the complex interplay between drug waste management and diversion prevention, advocating for comprehensive strategies that address both the practical and ethical dimensions of pharmaceutical care.
Panel
Matthew Farley, PharmD, CPHIMS
Director, Medication Technology and Analytics
Fresenius Kabi
Mike Axelsen, PharmD, BCPS
Sr. Manager, Medication Technology and Analytics
Fresenius Kabi
Adam Beeler, PharmD, MS
Director, Pharmacy Services
Protenus
References
- •03:30 - IHFDA
- •28:08 - Continuous Observation Workflow Time Study to Assess Intravenous Push Waste
- •35:15 - ASHP Drug Diversion Guidelines
- •47:54 - 2023 Diversion Digest